Opioid agonist treatments (methadone, buprenorphine): what they're for, and what's wrongly said about them
What opioid substitution treatment is
Opioid substitution treatment (OST) is a medication prescribed as part of medical care for opioid dependence (heroin, diverted morphine, certain opioid painkillers). Its goal is to stabilise the person — removing withdrawal symptoms and the overdose risk tied to street drugs of uncertain quality — so that ongoing medical, psychological and social support becomes possible. It isn't a recreational substance or an improvised stopgap: it's a regulated treatment, prescribed and monitored by a doctor.
This article gives no dosage or protocol details: only a doctor can assess the right treatment for an individual situation.
Two molecules, two prescribing frameworks
In France, two molecules are mainly used: methadone and buprenorphine. Their prescribing frameworks differ. Methadone requires initiation in a specialised setting (a CSAPA or hospital service), with community-based follow-up possible afterwards. Buprenorphine can be prescribed more broadly by a GP from the start, which often makes it a more accessible entry point. These distinctions are strictly medical decisions — mentioned here for information only, with no suggestion of which to choose.
Good to know. The choice between methadone and buprenorphine, like dosage, is strictly a matter for individual medical assessment. No online content can substitute for that.
The misconception: "you're just swapping one addiction for another"
This is the most common objection, and it deserves to be addressed. OST isn't designed to produce a sought-after effect in itself: at a stabilised dose, it doesn't produce the euphoria associated with street opioid use, and its goal is precisely to break the seek-crave-use cycle, not reproduce it with another substance. Physical dependence on the substitute molecule does exist, but it sits within a stable, medically supervised setting, without the risks tied to uncontrolled use (overdose, cutting agents, unsafe sourcing).
What the IGAS report highlights
A report by France's Inspection générale des affaires sociales (IGAS), published on 2 September 2026, identifies medical workforce shortages as a major barrier to accessing these treatments — particularly for initial prescriptions and renewals in certain areas. The IGAS recommends securing access, notably through a better distribution of prescribing capacity between community medicine and specialised facilities. This institutional finding reflects a reality many patients face: finding a prescriber, or switching one, can be harder than expected depending on where you live.
Worth noting. Never stop, change, or share a substitution treatment without medical advice — including if you're struggling to renew a prescription: talking to the prescribing doctor or a specialised centre is the right approach.
A strictly medical prescription
These treatments are never shared, lent, or self-adjusted. Any change — increasing, decreasing, stopping — must go through the prescribing doctor. This is a core safety principle, consistently reinforced by specialised services.
How it fits with broader support
OST addresses the physical dimension of dependence, but usually isn't enough on its own. An addiction specialist, or broader addiction care, complements this medical follow-up by working on triggers, craving, and life context — medication stabilisation is a step, not an endpoint.
Frequently asked questions
Is OST a lifelong treatment?
Its duration is decided with the prescribing doctor, based on each situation. Some people stay on treatment for years, others taper off gradually after stabilising — there's no general rule.
Can you come off methadone or buprenorphine themselves?
Stopping is possible but must always be gradual and medically supervised, never decided or carried out alone.
Why can it be hard to find a prescriber?
The September 2026 IGAS report points to a shortage of prescribing doctors in certain areas as a genuine barrier to access — not an individual failing, but a healthcare system organisation issue.
Does OST replace psychological support?
No. It addresses physical dependence, but addiction care remains useful for working through other dimensions (triggers, context, craving).
This article is for general information only and does not replace individual medical advice. No dosage information is provided: only a doctor can assess a treatment. Browse our other articles on addiction or subscribe to our newsletter.
